---
title: "Alphabet and Meta buy a year's head start on Biohub's $1.8 billion biology data; the protein model ships free"
description: "Biohub, the DOE and NIH committed $1.8 billion on October 7 to AI-ready biological data. Corporate funders get a one-year head start; the ESM protein models, once a $142 million venture bet, now ship free under an MIT license."
publisher: "The Inference"
section: "Health"
published: 2026-10-12T03:01:49.149Z
modified: 2026-10-12T03:01:49.149Z
canonical: https://theinference.org/article/alphabet-and-meta-buy-a-year-s-head-start-on-biohub-s-1-8-billion-biology-data-the-protein-model-ships-free
language: en
keywords: "Biohub, Meta, Alphabet, Drug Discovery, Biotech"
---

# Alphabet and Meta buy a year's head start on Biohub's $1.8 billion biology data; the protein model ships free

> Biohub, the DOE and NIH committed $1.8 billion on October 7 to AI-ready biological data. Corporate funders get a one-year head start; the ESM protein models, once a $142 million venture bet, now ship free under an MIT license.

## A $1.8 billion pot with one nonprofit at the center

On October 7, Biohub, the Department of Energy, the National Institutes of Health and new tech funders [committed $1.8 billion in funding, data, computation and measurement technology](https://www.biospace.com/press-releases/international-cross-sector-collaboration-commits-nearly-2-billion-to-build-foundational-data-for-ai-models-to-predict-and-treat-disease) to generate AI-ready biological data, which organizers call the largest coordinated commitment of its kind to date [1][2]. The commitment reprices two camps at once: vendors selling AI protein design, and the $142 million seed bet on [EvolutionaryScale](https://theinference.org/markets/companies/evolutionaryscale), whose frontier models became free infrastructure when the lab folded into Biohub [3].

The head of science at the center of it, Alex Rives, was a year earlier chief scientist of EvolutionaryScale, a venture-backed frontier lab that no longer exists as an independent company [1][3].

## The rival model is the free one

EvolutionaryScale [raised a $142 million seed](https://www.genengnews.com/topics/artificial-intelligence/biohub-releases-protein-biology-world-model-to-address-disease/) in 2024, led by Nat Friedman, Daniel Gross and Lux Capital, with [AWS](https://theinference.org/markets/companies/amazon) and [Nvidia](https://theinference.org/markets/companies/nvidia)'s NVentures aboard [3]. In November 2025 the Chan Zuckerberg Initiative folded its biomedical research into Biohub, [a step Reuters describes as including the acquisition of the startup](https://finance.yahoo.com/news/zuckerbergs-philanthropic-venture-unveils-ai-120331624.html); Rives took the top science job, and Biohub pledged a tenfold compute expansion to 10,000 GPUs by 2028 [4][5].

[The lab's own site now states EvolutionaryScale is part of Biohub](https://www.evolutionaryscale.ai/), with ESM models, APIs and services moved to biohub.ai under Biohub's terms [6]. What the seed holders received is undisclosed.

In May the team released ESMFold2: designed binders against five cancer and immunology targets, lab hit rates of 36% to 88% for mini-binders, nanomolar affinity, benchmarked against [Google DeepMind](https://theinference.org/markets/companies/google-deepmind)'s AlphaFold 3 and [Chai Discovery](https://theinference.org/markets/companies/chai-discovery)'s Chai-1 [3]. Everything shipped under an MIT license, commercial use included [3].

*Chart: **Lab hit rates for ESMFold2-designed mini-binders ranged from 36% to 88% across five targets** Bar chart of ESMFold2 lab hit rates for designed mini-binders across five targets, from 36 percent on KRAS G12D to 88 percent on PD-L1*

*Designed mini-binders screened against five cancer and immunology targets, May 2026. Hit rates are the share of designed binders confirmed in the lab. Sources: Genetic Engineering & Biotechnology News, May 27, 2026. [3]*

## The $300 million buys a year, not the models

*Chart: **Corporate money is a sixth of the $1.8 billion pot** Bar chart comparing the four commitments behind the $1.8 billion: DOE, NIH's prior-investment datasets, Biohub, and the corporate tranche from Google DeepMind, Isomorphic Labs and Meta.*

*Announced commitments of funding, data, computation and measurement technology to the Virtual Biology Initiative, October 7, 2026. DOE and NIH commitments are 'more than' $500 million each; the NIH share is datasets from prior federal investment, not new cash. Sources: Biohub announcement via BioSpace; Reuters. [1][7]*

Corporate money buys time, not ownership. Funders get a [one-year exclusive window on the data](https://thenextweb.com/news/biohub-1-8bn-ai-biology-data-meta-google-deepmind) before it goes public [8][9], and the government-funded share carries no embargo [7]. "We have to have some incentive for commercial players to be a part of this, and the embargo period creates that," Rives said [8][9]. The rest of the pot is DOE's more than $500 million over five years through its Genesis Mission, NIH-coordinated datasets from more than $500 million in prior federal investment, and Biohub's founding $500 million [1][7].

## Who this reprices

Design-tool vendors such as Chai Discovery now sell against a lab-validated frontier model that anyone can download, and Biohub hands it out through partners including AWS Bio Discovery and SandboxAQ [3].

The listed touchpoints run in every direction: [Alphabet](https://theinference.org/markets/companies/alphabet) and [Meta](https://theinference.org/markets/companies/meta) as funders, Amazon as a seed backer whose cloud distributes the models, Nvidia as a seed backer whose chips will carry the initiative's compute [1][3]. The nonprofit at the center is financed by Mark Zuckerberg and Priscilla Chan's pledge of 99% of their Meta shares [5].

Rives plans to approach drugmakers and philanthropies next, with [a first dataset due in about a year](https://www.msn.com/en-us/money/general/us-government-google-join-zuckerberg-backed-biohub-in-1-8-billion-push-for-ai-biology-data/ar-AA2dL8va) and predictive models targeted within five [7]. Whether cellular biology exhibits the same scaling laws seen elsewhere in AI is the open question the whole pot rests on [9].

## Takeaway

Biohub, the DOE and NIH put $1.8 billion behind AI-ready biology data; corporate funders buy a one-year head start while the free, MIT-licensed ESM models undercut paid protein-design tools.

## Sources

1. [BioSpace (Biohub press release), "International, cross-sector collaboration commits nearly $2 billion to build foundational data for AI models to predict and treat disease," 7 October 2026](https://www.biospace.com/press-releases/international-cross-sector-collaboration-commits-nearly-2-billion-to-build-foundational-data-for-ai-models-to-predict-and-treat-disease)
2. [Bioengineer, "Global coalition commits $1.8 billion to build open data for AI models of biology," 7 October 2026](https://bioengineer.org/global-coalition-commits-1-8-billion-to-build-open-data-for-ai-models-of-biology/)
3. [Genetic Engineering & Biotechnology News, "Biohub Releases Protein Biology World Model to Address Disease," 27 May 2026](https://www.genengnews.com/topics/artificial-intelligence/biohub-releases-protein-biology-world-model-to-address-disease/)
4. [PR Newswire via Yahoo Finance, "Biohub Launches First Large-Scale Scientific Initiative Combining Frontier AI with Frontier Biology to Cure or Prevent Disease," 6 November 2025](https://finance.yahoo.com/news/biohub-launches-first-large-scale-143000631.html)
5. [Reuters via Yahoo Finance, "Zuckerberg's philanthropic venture unveils AI world model for drug discovery," 27 May 2026](https://finance.yahoo.com/news/zuckerbergs-philanthropic-venture-unveils-ai-120331624.html)
6. [EvolutionaryScale website, "EvolutionaryScale is now part of Biohub," accessed 11 October 2026](https://www.evolutionaryscale.ai/)
7. [Reuters (Krystal Hu) via MSN, "US government, Google join Zuckerberg-backed Biohub in $1.8 billion push for AI biology data," 7 October 2026](https://www.msn.com/en-us/money/general/us-government-google-join-zuckerberg-backed-biohub-in-1-8-billion-push-for-ai-biology-data/ar-AA2dL8va)
8. [The Next Web, "Biohub, Meta, Google DeepMind and the US pool $1.8bn for AI biology data," 7 October 2026](https://thenextweb.com/news/biohub-1-8bn-ai-biology-data-meta-google-deepmind)
9. [Axios (Ina Fried) via MSN, "The beginning of a new scientific paradigm: Zuckerberg's Biohub, US and Google build virtual cell," 7 October 2026](https://www.msn.com/en-us/news/other/the-beginning-of-a-new-scientific-paradigm-zuckerbergs-biohub-us-and-google-build-virtual-cell/ar-AA2dKDKP)


---

Alphabet and Meta buy a year's head start on Biohub's $1.8 billion biology data; the protein model ships free — The Inference. Canonical: https://theinference.org/article/alphabet-and-meta-buy-a-year-s-head-start-on-biohub-s-1-8-billion-biology-data-the-protein-model-ships-free